A randomized trial of moderately early low-dose dexamethasone therapy in very low birth weight infants: Dynamic pulmonary mechanics, oxygenation, and ventilation

Pediatrics

Volumn 109, Issue 2 I, 2002, Pages 262-268

  Durand, Manuel ^a,c   Mendoza, Maria E ^b   Tantivit, Phuket ^a   Kugelman, Amir ^a   McEvoy, Cindy ^a  

^a LAC USC MEDICAL CENTER   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c WOMEN S AND CHILDREN S HOSPITAL   (United States)

Author keywords

Dynamic respiratory compliance; Low dose dexamethasone; Mean airway pressure; Oxygenation; Very low birth weight infants

Indexed keywords

DEXAMETHASONE;

AIRWAY PRESSURE; ARTICLE; ARTIFICIAL VENTILATION; BLOOD PRESSURE; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LUNG COMPLIANCE; LUNG MECHANICS; LUNG RESISTANCE; LUNG VENTILATION; MALE; NEWBORN; OXYGEN THERAPY; OXYGENATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TIDAL VOLUME; VERY LOW BIRTH WEIGHT;

ANTI-INFLAMMATORY AGENTS; BRONCHOPULMONARY DYSPLASIA; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; LUNG COMPLIANCE; LUNG DISEASES; PROSPECTIVE STUDIES; PROTEASE INHIBITORS; PULMONARY VENTILATION; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RESPIRATORY FUNCTION TESTS; RESPIRATORY MECHANICS; TREATMENT OUTCOME;

EID: 0036159199     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.109.2.262     Document Type: Article

References (40)

1. Scientific basis and therapeutic regimens for use of antenatal glucocorticoids
2. Pathogenesis and prevention of neonatal chronic lung disease: Recent developments
3. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: A sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates
4. The role of inflammation in the pathogenesis of bronchopulmonary dysplasia
5. Lung development and function in preterm infants in the surfactant treatment era
6. Effects of dexamethasone on chemotactic activity and inflammatory mediators in tracheobronchial aspirates of preterm infants at risk for chronic lung disease
7. Effect of dexamethasone on pulmonary inflammation and pulmonary function of ventilator-dependent infants with bronchopulmonary dysplasia
8. Effect of dexamethasone therapy on fibronectin and albumin levels in lung secretions of infants with bronchopulmonary dysplasia
9. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia
10. Dexamethasone therapy in neonatal chronic lung disease: An international placebo-controlled trial
11. Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: A randomized, controlled trial
12. Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birth weight infant
13. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants (Cochrane Review)
14. Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease
15. Pulmonary mechanics in premature infants one month after treatment with synthetic surfactant
16. Serial determination of pulmonary function in infants with chronic lung disease
17. Tidal volume and respiratory frequency in infants with bronchopulmonary dysplasia (BPD)
18. Pulmonary effect of inhaled furosemide in ventilated infants with severe bronchopulmonary dysplasia
19. Characterization of pulsatile secretion and clearance of plasma cortisol in premature and term neonates using deconvolution analysis
20. Neonatal pulmonary mechanics and oxygenation after prophylactic amnioinfusion in labor: A randomized clinical trial
21. Pulmonary mechanics and energetics in preterm infants who had respiratory distress syndrome treated with synthetic surfactant
22. Spontaneous desaturations in intubated very low birth weight infants with acute and chronic lung disease
23. A forced perturbation method of assessing pulmonary mechanical function in intubated infants
24. Prone positioning decreases episodes of hypoxemia in extremely low birth weight infants (1000 grams or less) with chronic lung disease
25. Adverse effects of early dexamethasone treatment in extremely low birth weight infants
26. Blood pressure in very low birth weight infants in the first 70 days of life
27. Pulmonary surfactant therapy
28. Effect of corticosteroids for fetal maturation on perinatal outcomes, February 28-March 2, 1994. National Institutes of Health Consensus Development Conference Statement
29. Functional residual capacity and passive compliance measurements after antenatal steroid therapy in preterm infants
30. Timing of antenatal corticosteroids and neonatal pulmonary mechanics
31. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants (Cochrane Review)
32. Side effects of 2 different dexamethasone courses for preterm infants at risk of chronic lung disease: A randomized trial
33. Early dexamethasone therapy in preterm infants: A follow-up study
34. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: Outcome of study participants at 1-year adjusted age
35. Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia
36. Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: A double-blind, controlled study
37. Pulmonary compliance in sick low birth weight infants: How reliable is the measurement of oesophageal pressure?
38. Liquid-filled esophageal catheter for measuring pleural pressure in preterm neonates
39. Compliance of the respiratory system in newborn infants pre- and post-surfactant replacement therapy
40. Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants